Teva Pharmaceutical Industries Ltd. ADR-0.06% $20.31B ...

After hours: October 18 at 7:42 PM EDT Loading Chart for GSK ...

Shares in GSK fell around 9% this morning after a judge in a Delaware court gave the green light for tens of thousands of lawsuits claiming harm by gastrointestinal drug Zantac to proceed to trial.

Ben Hargreaves examines the reasons supplied by the survey and why GSK is invested in the answers. The emergence of COVID-19 meant that public awareness around vaccination and its importance in ...

After hours: October 18 at 7:42 PM EDT ...

FDA accepted GSK's gepotidacin application for uUTI treatment with a PDUFA date set for March 26, 2025. Gepotidacin showed superior efficacy over nitrofurantoin in EAGLE-3 trial with a 58.5% ...

With Pfizer’s stock down sharply, an activist investor is pushing for something new from the CEO who spurred the company to ...

The first rollout of the vaccine will be in Bayelsa and Kebbi, two states with high seasonal transmission of malaria.

incorporated in the year 1924, is a Large Cap company (having a market cap of Rs 45,050.15 Crore) operating in Pharmaceuticals sector. GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue ...